Marjo van der Knaap
Dutch neurologist and professor

Marjo S. van der Knaap is a renowned Dutch neurologist and professor, known for her pioneering work in the field of neuroimaging and leukodystrophy. Her research has significantly advanced the understanding of white matter disorders in the human brain.
Early Life and Education[edit]
Marjo van der Knaap was born in the Netherlands. She pursued her medical degree at the University of Amsterdam, where she developed an interest in neurology and neuroimaging. Her early academic career was marked by a focus on the study of brain disorders, particularly those affecting the white matter.
Career[edit]
Van der Knaap began her career as a neurologist, quickly establishing herself as a leading expert in the field of pediatric neurology. She joined the VU University Medical Center in Amsterdam, where she has spent much of her career. Her work has been instrumental in the development of advanced neuroimaging techniques, which have improved the diagnosis and understanding of various neurological conditions.
Research Contributions[edit]
Van der Knaap is best known for her research on leukodystrophies, a group of rare genetic disorders that affect the white matter of the brain. Her work has led to the identification of several new types of leukodystrophies, expanding the medical community's understanding of these complex conditions.
Her research has also focused on the use of magnetic resonance imaging (MRI) to study brain abnormalities. Van der Knaap's innovative use of MRI has allowed for more accurate diagnoses and has provided deeper insights into the progression of white matter diseases.
Awards and Recognition[edit]
Throughout her career, Marjo van der Knaap has received numerous awards and honors for her contributions to neurology and medical research. Her work has been recognized internationally, and she is frequently invited to speak at conferences and symposia around the world.
Legacy[edit]
Marjo van der Knaap's work has had a profound impact on the field of neurology, particularly in the study of white matter disorders. Her research has not only improved diagnostic techniques but has also paved the way for new treatments and therapies for patients with leukodystrophies and other related conditions.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian